Cargando...
Clinical efficacy and safety of rituximab in lupus nephritis
BACKGROUND: Long-term treatment programs with low toxicity represent a therapeutic challenge in lupus nephritis (LN). Although a therapeutic benefit of rituximab (RTX) has been reported in LN patients who have failed conventional treatment, the results are controversial. We aimed to assess the clini...
Guardado en:
| Publicado en: | Drug Des Devel Ther |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6417005/ https://ncbi.nlm.nih.gov/pubmed/30880917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S195113 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|